Announced Sun, 31 May · 18:15 IST

Newspaper publication of Financial Results March, 2026.

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-7.1%1-day move
₹56.00
prior close
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-7.1-2.9+5.4+17.0+21.1+36.8+42.2+39.3
Up moveDown movePending
AI summary

Novelix Pharmaceuticals Ltd (formerly TRIMURTHI LIMITED) has submitted newspaper publications of its audited standalone financial results for Q4 and the full year ended 31 March 2026. The results were published on 30 May 2026 in 'The Business Standard' (English) and 'The Nirbhaya Vaartha' (Telugu), Hyderabad editions, in compliance with SEBI LODR Regulation 47. The full financial details were reviewed by the Audit Committee and approved by the Board of Directors on 29 May 2026. The company has changed its name from TRIMURTHI LIMITED to Novelix Pharmaceuticals Limited, with CIN L67120TG1994PLC018956. The filing was made by Venkateshwarlu Pulluru, Whole-time Director.

Likely market impact

Routine compliance filing confirming newspaper publication of annual and quarterly results. No direct stock price impact from this disclosure alone, as the underlying financial results were already approved by the board.